MEDIVIR Aktie

6,40 EUR 0,2035%

Zu Ihrem Onlinebroker

kaufen verkaufen

MEDIVIR Aktienkurs : 25.05. ( 15 Min. verzögert)
6,40 € Letzter Kurs	0,20% Veränderung	6,39 € Vortag	6,40 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
6,40 - 6,40 Tag	15,91 - 6,18 52 Wochen	0 Tag	37 Ø 52 Wochen	6,48 700 Stücke	6,61 700 Stücke

MEDIVIR Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

Vitrolife AB (publ): Vitrolife named as winner of the 2012 SwedenBIO Award

This year's prize is the sixth to be awarded and previous winners are Aerocrine, BioInvent, Cellavision, Medivir and Gyros. "We are extremely proud to have been awarded this distinction. We see the award as a result of...
21.05.

BioTrends Research GroupPosted on:21 May 12

However, GS-7977 and Tibotec / Medivir‚Äôs TMC-435 are anticipated to bring the most value to practices for the treatment of HCV, primarily due to GS-7977‚Äôs efficacy in trials, pan-genotype usage a…

21.05.

BioTrends Research GroupPosted on:21 May 12

However, GS-7977 and Tibotec / Medivir‚Äôs TMC-435 are anticipated to bring the most value to practices for the treatment of HCV, primarily due to GS-7977‚Äôs efficacy in trials, pan-genotype usage a…
17.05.

Medivir appoints commercial executive vice president

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company's commercial activities. Juserius who will have overall responsibility...
15.05.

Medivir: New Executive Vice President Commercial Appointed

Medivir AB (sto:MVIRB), a research-based specialty pharmaceutical company focused on infectious diseases, announced today that it has appointed Henric Juserius to be the new head of the company's…